| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |